Characteristic | No. (%) of cases |
---|---|
Patient sex | |
Female | 2 501 130 (48.1) |
Male | 2 697 430 (51.9) |
Patient age, yr | |
20–29 | 76 890 (1.5) |
30–39 | 179 760 (3.5) |
40–49 | 430 600 (8.3) |
50–59 | 899 170 (17.3) |
60–69 | 1 398 270 (26.9) |
70–79 | 1 389 585 (26.7) |
80–89 | 824 285 (15.9) |
Period | |
1971–1975 | 277 540 (5.3) |
1976–1980 | 347 000 (6.7) |
1981–1985 | 427 145 (8.2) |
1986–1990 | 490 550 (9.4) |
1991–1995 | 581 280 (11.2) |
1996–2000 | 641 025 (12.3) |
2001–2005 | 728 920 (14.0) |
2006–2010 | 824 715 (15.9) |
2011–2015 | 880 385 (16.9) |
Cancer site or type | |
Acute myeloid leukemia | 33 230 (0.6) |
Anus | 15 750 (0.3) |
Bladder | 236 845 (4.6) |
Breast | 699 430 (13.5) |
Cervix | 65 015 (1.3) |
Chronic myeloid leukemia | 17 625 (0.3) |
Colon and rectum | 688 305 (13.2) |
Esophagus | 51 470 (1.0) |
Gallbladder | 17 945 (0.3) |
Kidney and renal pelvis | 133 210 (2.6) |
Larynx | 48 995 (0.9) |
Liver | 41 900 (0.8) |
Lung and bronchus | 759 050 (14.6) |
Multiple myeloma | 64 585 (1.2) |
Non-Hodgkin lymphoma | 195 690 (3.8) |
Oral | 138 665 (2.7) |
Ovary | 89 070 (1.7) |
Pancreas | 131 885 (2.5) |
Prostate | 611 140 (11.8) |
Skin melanoma | 140 060 (2.7) |
Stomach | 132 075 (2.5) |
Thyroid | 97 935 (1.9) |
Testis | 27 575 (0.5) |
Uterus | 153 820 (3.0) |
All cancers | 5 198 560 (100.0) |